Exact Mass: 590.1846764000001
Exact Mass Matches: 590.1846764000001
Found 143 metabolites which its exact mass value is equals to given mass value 590.1846764000001
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Maysin 3'-methyl ether
Maysin 3-methyl ether is found in cereals and cereal products. Maysin 3-methyl ether is isolated from corn silk (Zea mays). Isolated from corn silk (Zea mays). Maysin 3-methyl ether is found in cereals and cereal products and corn.
4'-Hydroxyanigorootin
4-Hydroxyanigorootin is found in fruits. 4-Hydroxyanigorootin is a constituent of the rhizomes of Musa acuminata (dwarf banana). Constituent of the rhizomes of Musa acuminata (dwarf banana). 4-Hydroxyanigorootin is found in fruits.
Corrigendum
Grape seed extract
Lusutrombopag
B - Blood and blood forming organs > B02 - Antihemorrhagics > B02B - Vitamin k and other hemostatics C78275 - Agent Affecting Blood or Body Fluid
Matterionate B
12-Dihydrodalbin
4-[4-(3-Methyl-2,3-dihydroxybutoxy)-5,5-dimethylspiro[7H-furo[3,2-g][1]benzopyran-7,2-[1,3]dioxolane]-4-ylmethoxy]-7H-furo[3,2-g][1]benzopyran-7-one
Amorphigenol O-glucoside
isotriuvaretin
Triuvaretin
(2,2-Bianthracene)-8,8(5H,5H)-dione, 6,6,7,7-tetrahydro-1,1,5,6,6,9,9-heptahydroxy-3,3-dimethoxy-6,6-dimethyl-
4-[(6-O-[5-O-(4-hydroxybenzoyl)-beta-D-apiofuranosyl]-beta-D-glucopyranosyl)oxy]-5-methyl-2H-1-benzopyran-2-one|diosfeboside B
O-alpha-L-arabinofuranosyl-(1<*>3)-O-(2-O-trans-feruloyl-alpha-L-arabinofuranosyl)-(1<*>5)-alpha-L-arabinofuranose|O-alpha-L-arabinofuranosyl-(1[*]3)-O-(2-O-trans-feruloyl-alpha-L-arabinofuranosyl)-(1[*]5)-alpha-L-arabinofuranose
2,3,5-Tribenzoyl,picrate-beta-D-Ribazole|2,3,5-Tribenzoyl-alpha-D-Ribazole|2,3,5-Tribenzoyl-beta-D-Ribazole
23-alpha-D-glucuronopyranosyl-1,4-beta-D-xylotriose
O-(5-O-feruloyl-alpha-L-arabinofuranosyl)-(1-->3)-O-beta-D-xylopyranosyl-(1-->4)-D-xylopyranose|O-(5-O-feruloyl-alpha-L-arabinofuranosyl)-(1-3)-O-beta-D-xylopyranosyl-(1-4)-D-xylopyranose|O-<5-O-(trans-feruloyl)-alpha-L-arabinofuranosyl>-(1<*>3)-O-beta-D-xylopyranosyl-(1<*>4)-D-xylopyranose|O-[5-O-(E-feruloyl)-alpha-L-arabinofuranosyl](1->3)-O-beta-D-xylopyranosyl-(1->4)-D-xylopyranose
eugenol-O-[beta-D-xylopyranosyl-(1->5)-O-beta-D-apiofuranosyl-(1->6)-O-beta-D-glucopyranoside]
14-O-(4-Hydroxysenecioyl)isovernocistifolid-8-O-angelat
methyl 4,4-bis(6-((E)-3,4-dihydroxystyryl)-4-hydroxy-2-oxo-2H-pyran-3-yl)butanoate|phaeolschidin D
1beta,8beta-difuranoyl-4alpha,5alpha-dihydroxy-7beta,11-diacetoxydihydroagarofuran|triptersinine I
1beta,11beta-diacetoxy-4alpha,7beta-dihydroxy-5alpha,8beta-difuranoyldihydroagarofuran|triptersinine J
14-hydroxyhypocretenolide-beta-D-glucopyranoside tetraacetate
2-(3,4-Dihydroxyphenyl)-3,3,4,4-tetrahydro-3,3,5,7,7-pentahydroxy-2-(4-hydroxyphenyl)-4,6-bi[2H-1-benzopyran]-8-carboxylic acid
2-(3,4-Dihydroxyphenyl)-3,3,4,4-tetrahydro-3,3,5,7,7-pentahydroxy-2-(4-hydroxyphenyl)-4,8-bi[2H-1-benzopyran]-6-carboxylic acid
Cys Pro Trp Trp
Cys Trp Pro Trp
Cys Trp Trp Pro
Asp Met Tyr Tyr
Asp Tyr Met Tyr
Asp Tyr Tyr Met
Glu Glu Gln Trp
Glu Glu Trp Gln
Glu Gln Glu Trp
Glu Gln Trp Glu
Glu Trp Glu Gln
Glu Trp Gln Glu
Phe Met Met Tyr
Phe Met Tyr Met
Phe Tyr Met Met
Met Asp Tyr Tyr
Met Phe Met Tyr
Met Phe Tyr Met
Met Met Phe Tyr
Met Met Tyr Phe
Met Tyr Asp Tyr
Met Tyr Phe Met
Met Tyr Met Phe
Met Tyr Tyr Asp
Pro Cys Trp Trp
Pro Trp Cys Trp
Pro Trp Trp Cys
Gln Glu Glu Trp
Gln Glu Trp Glu
Gln Trp Glu Glu
Trp Cys Pro Trp
Trp Cys Trp Pro
Trp Glu Glu Gln
Trp Glu Gln Glu
Trp Pro Cys Trp
Trp Pro Trp Cys
Trp Gln Glu Glu
Trp Trp Cys Pro
Trp Trp Pro Cys
Tyr Asp Met Tyr
Tyr Asp Tyr Met
Tyr Phe Met Met
Tyr Met Asp Tyr
Tyr Met Phe Met
Tyr Met Met Phe
Tyr Met Tyr Asp
Tyr Tyr Asp Met
Tyr Tyr Met Asp
3'-O-Methylmaysin
4'-Hydroxyanigorootin
1,2,3,4-Tetra-O-acetyl-6-O-triphenylmethyl-beta-D-glucopyranose
Adipic acid, propylene glycol, isophthalic acid, neopentyl glycol, maleic anhydride polymer
Vorapaxar sulfate
C78275 - Agent Affecting Blood or Body Fluid > C1327 - Antiplatelet Agent D006401 - Hematologic Agents > D010975 - Platelet Aggregation Inhibitors C78274 - Agent Affecting Cardiovascular System
2,6-Dimethylcarbonylphenyl-10-sulfopropylacridinium-9-carboxylate 4-NHS Ester
(R)-(E)-3-(2,6-dichloro-4-{4-[2-methyloxy-3-(1-hexyloxyethyl)phenyl]thiazol-2-ylcarbamoyl}phenyl)-2-methylacrylic acid
Butanamide, 2,2-[(3,3-dichloro[1,1-biphenyl]-4,4-diyl)bis(azo)]bis[3-oxo-, N,N-bis(p-anisyl and Ph) derivs.
Cindunistat hydrochloride maleate
C20H39ClN6O8S2 (590.1959204000001)
C471 - Enzyme Inhibitor
Lusutrombopag
B - Blood and blood forming organs > B02 - Antihemorrhagics > B02B - Vitamin k and other hemostatics C78275 - Agent Affecting Blood or Body Fluid
Glu-Glu-Gln-Trp
A pentapeptide composed of two L-glutamic acid units, L-glutamine and L-tryptophan joined in sequence by peptide linkages.
N-[[(10R,11S)-13-[(2S)-1-hydroxypropan-2-yl]-11-methyl-14-oxo-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-10-yl]methyl]-N-methyl-4-(trifluoromethyl)benzenesulfonamide
N-[[(10S,11S)-13-[(2S)-1-hydroxypropan-2-yl]-11-methyl-14-oxo-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-10-yl]methyl]-N-methyl-4-(trifluoromethyl)benzenesulfonamide
N-[[(10S,11R)-13-[(2R)-1-hydroxypropan-2-yl]-11-methyl-14-oxo-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-10-yl]methyl]-N-methyl-4-(trifluoromethyl)benzenesulfonamide
N-[[(10S,11S)-13-[(2R)-1-hydroxypropan-2-yl]-11-methyl-14-oxo-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-10-yl]methyl]-N-methyl-4-(trifluoromethyl)benzenesulfonamide
N-[[(10R,11R)-13-[(2S)-1-hydroxypropan-2-yl]-11-methyl-14-oxo-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-10-yl]methyl]-N-methyl-4-(trifluoromethyl)benzenesulfonamide
N-[[(10R,11S)-13-[(2R)-1-hydroxypropan-2-yl]-11-methyl-14-oxo-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-10-yl]methyl]-N-methyl-4-(trifluoromethyl)benzenesulfonamide
N-[[(10R,11R)-13-[(2R)-1-hydroxypropan-2-yl]-11-methyl-14-oxo-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-10-yl]methyl]-N-methyl-4-(trifluoromethyl)benzenesulfonamide
(2S,3S,4S,5R,6S)-3,4,5-trihydroxy-6-[(2S,3R,4S,5R)-4-hydroxy-5-[(2S,3R,4S,5R)-3,4,5-trihydroxyoxan-2-yl]oxy-2-[(3R,4R,5R,6R)-4,5,6-trihydroxyoxan-3-yl]oxyoxan-3-yl]oxyoxane-2-carboxylic acid
4-Hydroxy-4-(11,16,18-trihydroxy-7-methoxycarbonyl-20-methyl-9,14,23-trioxo-6-oxahexacyclo[11.10.2.01,15.03,12.05,10.017,22]pentacosa-3,5(10),11,15,17(22),18,20,24-octaen-7-yl)butanoic acid
CGP 20712 A
C24H29F3N4O8S (590.1658110000001)
CGP 20712 A (CGP 20712 mesylate) is a highly selective β1-adrenoceptor antagonist with an IC50 of 0.7 nM. CGP 20712 A exhibits ~10,000-fold selectivity over β2-adrenoceptors[1].
3-hydroxy-3-methyl-5-oxo-5-{[(2r,3s,4s,5r,6s)-3,4,5-trihydroxy-6-{[(2s)-5-hydroxy-6,8-dimethyl-4-oxo-2-phenyl-2,3-dihydro-1-benzopyran-7-yl]oxy}oxan-2-yl]methoxy}pentanoic acid
[3,4,5-tris(acetyloxy)-6-({2-methyl-10-methylidene-4,11-dioxo-12-oxatricyclo[7.3.1.0¹,⁵]trideca-2,5-dien-6-yl}methoxy)oxan-2-yl]methyl acetate
[(3r,4s,5s)-3,4-dihydroxy-5-{[(2s,3r,4r,5s,6r)-3,4,5-trihydroxy-6-[(5-methyl-2-oxochromen-4-yl)oxy]oxan-2-yl]methoxy}oxolan-3-yl]methyl 4-hydroxybenzoate
(2r,3s,4r)-2-{[(2s,3r,4r,5r,6r)-5-{[(2s,3s,4r,5s,6r)-3-amino-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-3,4-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-4-[(2s,3r,4r,5r)-3,4-dihydroxy-5-(hydroxymethyl)pyrrolidin-2-yl]-3,4-dihydroxybutanoic acid
C21H38N2O17 (590.2170378000001)
(2r,3s,4s)-2-{[(2r,3r,4r,5r,6r)-5-{[(2s,3r,4s,5r,6r)-3-amino-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-3,4-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-4-[(2s,3s,4s,5s)-3,4-dihydroxy-5-(hydroxymethyl)pyrrolidin-2-yl]-3,4-dihydroxybutanoic acid
C21H38N2O17 (590.2170378000001)